Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-10

Clinical Trial Update: Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying alpha-lipoic acid as an adjuvant treatment for acute phosphide poisoning; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Heba Allah Ali Abd El-Halim Mabrouk | Conditions: Toxicity | Phase 2 | Status: UNKNOWN